WebA trivalent formulation, Fluzone® High-Dose, was previously authorized for use in adults 65 years of age in Canada, and recommended by NACI, but marketing of the vaccine has been discontinued as of February 2024. Based on a review of available pre-licensure clinical trial data and Health Canada’s Clinical Review Reports, NACI has concluded ... WebDo not administer this product intravenously. Fluzone High-Dose Quadrivalent should not be combined through reconstitution or mixed with any other vaccine. 3 DOSAGE FORMS AND STRENGTHS Fluzone ...
Influenza Vaccine Quadrivalent Inactivated High Dose - Alberta
WebAlberta Immunization Policy Biological Products ©2024 Government of Alberta Published: August, 2024 Page 1 of 2 Influenza Vaccine High-Dose Quadrivalent … Web• The product used will be: o Fluzone® High-Dose (Sanofi Pasteur) – this product contains four times the virus antigen per strain in comparison to the standard-dose influenza vaccine. Evidence indicates better protection for those 65 years and older compared to the standard-dose influenza vaccine. • The components of the vaccine include: ready go live abc
Our STN: BL 103914/6290 SUPPLEMENT APPROVAL - Food …
http://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/Part4/Influenza_IntendedUse.pdf WebFeb 13, 2024 · Fluzone High-Dose is indicated for active immunization of persons 65 years of age and older against influenza disease caused by influenza virus subtypes A and … WebSep 12, 2024 · Supemtek is considered effective, immunogenic, and safe in adults 18 years of age and older and has a comparable immunogenicity and safety profile to egg- and cell culture-based, inactivated, live attenuated, adjuvanted, and high-dose seasonal influenza vaccines already licensed in Canada. ready girl